Genomic and Precision Medicine. Infectious and Inflammatory Disease. Edition No. 3

Authors

Geoffrey S. Ginsburg Chief Medical and Scientific Officer, All of Us Research Program, National Institutes of Health, Bethesda, Maryland, USA. Dr. Ginsburg is the founding Director of the Center for Applied Genomics & Precision Medicine in the Duke Institute for Genome Sciences & Policy. He is also Professor of Medicine and of Pathology at Duke University Medical Center, Professor of Biomedical Engineering at Duke Pratt School of Engineering, and Co-Director of the Duke Translational Medicine Institute. Huntington F Willard Chief Scientific Officer, Genome Medical, Inc., South San Francisco, CA, USA. Huntington Willard is on the faculty of the Department of Human Genetics at the University of Chicago. Prior to this appointment, Willard was the President and Director of the Marine Biological Laboratory and Professor of Human Genetics at the University of Chicago. He was previously on the faculty at Duke University, where he was founding director of the university-wide Duke Institute for Genome Sciences & Policy from 2003 to 2014, the Nanaline H. Duke Professor of Genome Sciences, and the Arts & Sciences Professor of Biology & Genome Sciences. Christopher W. Woods Professor of Medicine and Global Health, Duke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine; Chief, Infectious Disease Division, Durham VA Health Care System, USA. Ephraim L. Tsalik Duke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine; Emergency Department Service, Durham VA Health Care System, USA.. Dr. Tsalik obtained his MD and PhD at Columbia University before coming to Duke for his clinical training in Internal Medicine followed by fellowship in Infectious Diseases. He is currently an Associate Professor of Medicine, Associate Professor of Molecular Genetics and Microbiology, and is a Physician in the Emergency Department at the Durham VA Health Care System. He is also Associate Director of Diagnostics for the Antibacterial Resistance Leadership Group. His research focuses on the host response to infection with a particular emphasis on translation to diagnostic tests.